Alcohol Consumption and Survival after a Breast Cancer Diagnosis: A Literature-Based Meta-analysis and Collaborative Analysis of Data for 29,239 Cases

DOI PDF 被引用文献1件
  • Alaa M.G. Ali
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Marjanka K. Schmidt
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Manjeet K. Bolla
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Qin Wang
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • M. Gago-Dominguez
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • J. Esteban Castelao
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Angel Carracedo
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Victor Muñoz Garzón
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Stig E. Bojesen
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Børge G. Nordestgaard
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Henrik Flyger
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Jenny Chang-Claude
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Alina Vrieling
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Anja Rudolph
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Petra Seibold
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Heli Nevanlinna
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Taru A. Muranen
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Kirsimari Aaltonen
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Carl Blomqvist
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Keitaro Matsuo
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Hidemi Ito
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Hiroji Iwata
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Akiyo Horio
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Esther M. John
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Mark Sherman
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Jolanta Lissowska
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Jonine Figueroa
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Montserrat Garcia-Closas
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Hoda Anton-Culver
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Mitul Shah
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • John L. Hopper
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Antonia Trichopoulou
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Bas Bueno-de-Mesquita
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Vittorio Krogh
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Elisabete Weiderpass
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Anne Andersson
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Françoise Clavel-Chapelon
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Laure Dossus
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Guy Fagherazzi
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Petra H. Peeters
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Anja Olsen
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Gordon C. Wishart
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Douglas F. Easton
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Signe Borgquist
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Kim Overvad
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Aurelio Barricarte
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Carlos A. González
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • María-José Sánchez
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Pilar Amiano
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Elio Riboli
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Tim Key
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the
  • Paul D. Pharoah
    Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the

この論文をさがす

説明

<jats:title>Abstract</jats:title> <jats:p>Background: Evidence for an association of alcohol consumption with prognosis after a diagnosis of breast cancer has been inconsistent. We have reviewed and summarized the published evidence and evaluated the association using individual patient data from multiple case cohorts.</jats:p> <jats:p>Methods: A MEDLINE search to identify studies published up to January 2013 was performed. We combined published estimates of survival time for “moderate drinkers” versus nondrinkers. An analysis of individual participant data using Cox regression was carried out using data from 11 case cohorts.</jats:p> <jats:p>Results: We identified 11 published studies suitable for inclusion in the meta-analysis. Moderate postdiagnosis alcohol consumption was not associated with overall survival [HR, 0.95; 95% confidence interval (CI), 0.85–1.05], but there was some evidence of better survival associated with prediagnosis consumption (HR, 0.80; 95% CI, 0.73–0.88). Individual data on alcohol consumption for 29,239 cases with 4,839 deaths were available from the 11 case cohorts, all of which had data on estrogen receptor (ER) status. For women with ER-positive disease, there was little evidence that pre- or postdiagnosis alcohol consumption is associated with breast cancer–specific mortality, with some evidence of a negative association with all-cause mortality. On the basis of a single study, moderate postdiagnosis alcohol intake was associated with a small reduction in breast cancer–specific mortality for women with ER-negative disease. There was no association with prediagnosis intake for women with ER-negative disease.</jats:p> <jats:p>Conclusion: There was little evidence that pre- or post-diagnosis alcohol consumption is associated with breast cancer–specific mortality for women with ER-positive disease. There was weak evidence that moderate post-diagnosis alcohol intake is associated with a small reduction in breast cancer–specific mortality in ER-negative disease.</jats:p> <jats:p>Impact: Considering the totality of the evidence, moderate postdiagnosis alcohol consumption is unlikely to have a major adverse effect on the survival of women with breast cancer. Cancer Epidemiol Biomarkers Prev; 23(6); 934–45. ©2014 AACR.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ